Management is pursuing regulatory acceptance for iopofosine I 131 in WM, with a near-term focus on securing conditional approval in Europe. Caruso stated, "We will know from our friends at the EMA in ...
With the European Medicines Agency (EMA) adopting a recommendation report to streamline the clinical procedures for ...
Bengaluru, Sept. 23 -- Shares of a company manufacturing niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service, hit a 5 percent upper circuit, ...